Physician profile
Gregory A Thomas
NPI 1083624357
$16,028.29
in general payments reported to CMS, 2019-2025
31 companies · $493 in 2025
The $493 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $811 · 2020: $322 · 2021: $91.84 · 2022: $2,693 · 2023: $8,381 · 2024: $3,236 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,985 · Travel and Lodging: $3,768 · Food and Beverage: $2,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,985.00 |
| Travel and Lodging | $3,768.01 |
| Food and Beverage | $2,357.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $8,795.52 | 2021-2025 | Tisseel, Preveleak, Perclot |
| W. L. Gore & Associates, INC. | $3,476.90 | 2019-2023 | Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Abiomed | $1,263.94 | 2021-2025 | Impella |
| Atricure, INC. | $556.61 | 2020-2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| Intuitive Surgical, INC. | $360.02 | 2019-2024 | |
| Artivion, INC. | $281.88 | 2019-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Photofix Decellularized Bovine Pericardium |
| Medtronic, INC. | $233.52 | 2022-2023 | Illumisite |
| Cook Medical LLC | $170.42 | 2019-2024 | Cook |
| Covidien Lp | $161.20 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $94.74 | 2025 | |
| Kls-Martin L.P. | $53.15 | 2023 | |
| Zimmer Biomet Holdings, INC. | $50.65 | 2020 | |
| Olympus America INC. | $50.25 | 2019-2022 | |
| Elutia, INC. | $49.80 | 2019-2023 | |
| Nuwellis, INC. | $35.11 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $35.05 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $34.92 | 2022-2023 | Opdivo |
| Angiodynamics, INC. | $33.40 | 2025 | Angiovac |
| Bolton Medical INC | $33.01 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Tela Bio, INC. | $32.64 | 2022 | |
| Potrero Medical, INC. | $30.80 | 2023 | |
| Convatec INC. | $28.93 | 2024 | |
| Cook Biotech Incorporated | $27.21 | 2023 | Biodesign |
| Medtronic Vascular, INC. | $25.52 | 2019-2020 | |
| Prime Surgical, LLC | $20.97 | 2025 | |
| La Jolla Pharmaceutical Company | $20.86 | 2025 | Giapreza |
| Ethicon US, LLC | $15.32 | 2024 | Evarrest, Surgicel Nu-Knit |
| Boston Scientific Corporation | $15.32 | 2019 | |
| Lemaitre Vascular, INC. | $15.08 | 2023 | Tyke, Patch, Pledget and Intracardiac |
| Medela LLC | $13.95 | 2022 | |
| Conmed Corporation | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.